{"id":"https://openalex.org/W4386024142","doi":"https://doi.org/10.1097/01.hs9.0000968116.45317.31","title":"S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX","display_name":"S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX","publication_year":2023,"publication_date":"2023-08-01","ids":{"openalex":"https://openalex.org/W4386024142","doi":"https://doi.org/10.1097/01.hs9.0000968116.45317.31"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000968116.45317.31","doi":"https://doi.org/10.1097/01.hs9.0000968116.45317.31","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000968116.45317.31","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1097/01.hs9.0000968116.45317.31","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044350124","display_name":"Gili Kenet","orcid":"https://orcid.org/0000-0003-3494-9823","observed_orcids":["https://orcid.org/0000-0003-3494-9823"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Gili Kenet","raw_affiliation_strings":["Tel Aviv University, The National Hemophilia Centre, The Amalia Biron Thrombosis Research Institute, Sheba Medical Centre, Tel Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tel Aviv University, The National Hemophilia Centre, The Amalia Biron Thrombosis Research Institute, Sheba Medical Centre, Tel Aviv, Israel","institution_ids":["https://openalex.org/I16391192","https://openalex.org/I2799810450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058639047","display_name":"Beatrice Nolan","orcid":"https://orcid.org/0000-0003-0145-4736","observed_orcids":["https://orcid.org/0000-0003-0145-4736"]},"institutions":[{"id":"https://openalex.org/I3017411684","display_name":"Children's Health Ireland at Crumlin","ror":"https://ror.org/025qedy81","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I3017411684"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Beatrice Nolan","raw_affiliation_strings":["Children\u2019s Health Ireland at Crumlin, Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Health Ireland at Crumlin, Dublin, Ireland","institution_ids":["https://openalex.org/I3017411684"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056760268","display_name":"B\u00fclent Z\u00fclfikar","orcid":"https://orcid.org/0000-0002-7586-6939","observed_orcids":["https://orcid.org/0000-0002-7586-6939"]},"institutions":[{"id":"https://openalex.org/I67581229","display_name":"Istanbul University","ror":"https://ror.org/03a5qrr21","country_code":"TR","type":"education","lineage":["https://openalex.org/I67581229"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Bulent Zulfikar","raw_affiliation_strings":["Istanbul University Oncology Institute, Division of Pediatric Hematology-Oncology, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul University Oncology Institute, Division of Pediatric Hematology-Oncology, Istanbul, Turkey","institution_ids":["https://openalex.org/I67581229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062815612","display_name":"B\u00fclent Antmen","orcid":"https://orcid.org/0000-0001-6058-6021","observed_orcids":["https://orcid.org/0000-0001-6058-6021"]},"institutions":[{"id":"https://openalex.org/I322491407","display_name":"Ac\u0131badem University","ror":"https://ror.org/01rp2a061","country_code":"TR","type":"education","lineage":["https://openalex.org/I322491407"]},{"id":"https://openalex.org/I4210094594","display_name":"Adana Hospital","ror":"https://ror.org/0086skx40","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I4210094594","https://openalex.org/I4210127769"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Bulent Antmen","raw_affiliation_strings":["Acibadem University, Adana Hospital, Department of Pediatric Hematology/Oncology and Bone Marrow Transplantation Unit, Faculty of Medicine,, Adana, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acibadem University, Adana Hospital, Department of Pediatric Hematology/Oncology and Bone Marrow Transplantation Unit, Faculty of Medicine,, Adana, Turkey","institution_ids":["https://openalex.org/I322491407","https://openalex.org/I4210094594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004338432","display_name":"Guy A. Young","orcid":"https://orcid.org/0000-0001-6013-1254","observed_orcids":["https://orcid.org/0000-0001-6013-1254"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guy Young","raw_affiliation_strings":["Hemostasis and Thrombosis Center, Cancer and Blood Diseases Institute, Children\u2019s Hospital Los Angeles, University of Southern California Keck School of Medicine, LA, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hemostasis and Thrombosis Center, Cancer and Blood Diseases Institute, Children\u2019s Hospital Los Angeles, University of Southern California Keck School of Medicine, LA, CA, United States","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1336910626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113114351","display_name":"Jiarui Chi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiarui Chi","raw_affiliation_strings":["Sanofi, Bridgewater, New Jersey, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Bridgewater, New Jersey, United States","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019989437","display_name":"Marion Afonso","orcid":"https://orcid.org/0009-0007-7953-5954","observed_orcids":["https://orcid.org/0009-0007-7953-5954"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marion Afonso","raw_affiliation_strings":["Sanofi, Chilly-Mazarin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Chilly-Mazarin, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009262407","display_name":"Viridiana Cano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Viridiana Cano","raw_affiliation_strings":["Sanofi, Cambridge, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Cambridge, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058742448","display_name":"Christian Sussebach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Sussebach","raw_affiliation_strings":["Sanofi, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023662710","display_name":"Shauna R. Andersson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shauna Andersson","raw_affiliation_strings":["Sanofi, Cambridge, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Cambridge, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085306795","display_name":"Kaan Kavakl\u0131","orcid":"https://orcid.org/0000-0002-4910-2142","observed_orcids":["https://orcid.org/0000-0002-4910-2142"]},"institutions":[{"id":"https://openalex.org/I41641357","display_name":"Ege University","ror":"https://ror.org/02eaafc18","country_code":"TR","type":"education","lineage":["https://openalex.org/I41641357"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Kaan Kavakli","raw_affiliation_strings":["Kaan Department of Haematology, Ege University Faculty of Medicine, Children\u2019s Hospital, Izmir, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaan Department of Haematology, Ege University Faculty of Medicine, Children\u2019s Hospital, Izmir, Turkey","institution_ids":["https://openalex.org/I41641357"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"S3","first_page":"e4531731","last_page":"e4531731"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fitusiran","display_name":"fitusiran","score":0.9729999899864197},{"id":"https://openalex.org/keywords/hemophilia-a","display_name":"hemophilia A","score":0.9649999737739563},{"id":"https://openalex.org/keywords/hemophilia-b","display_name":"hemophilia B","score":1.0},{"id":"https://openalex.org/keywords/breakthrough-bleeding","display_name":"breakthrough bleeding","score":0.8140000104904175},{"id":"https://openalex.org/keywords/clotting-factor-concentrates","display_name":"clotting factor concentrates","score":0.8569999933242798},{"id":"https://openalex.org/keywords/bypassing-agents","display_name":"bypassing agents","score":0.996999979019165},{"id":"https://openalex.org/keywords/annualized-bleeding-rate","display_name":"annualized bleeding rate","score":0.7490000128746033},{"id":"https://openalex.org/keywords/factor-viii","display_name":"factor VIII","score":0.48100000619888306},{"id":"https://openalex.org/keywords/factor-ix","display_name":"factor IX","score":0.9670000076293945},{"id":"https://openalex.org/keywords/antithrombin-iii","display_name":"antithrombin III","score":0.6830000281333923},{"id":"https://openalex.org/keywords/factor-inhibitors","display_name":"factor inhibitors","score":0.3919999897480011},{"id":"https://openalex.org/keywords/activated-prothrombin-complex-concentrate","display_name":"activated prothrombin complex concentrate","score":0.9049999713897705},{"id":"https://openalex.org/keywords/recombinant-factor-viia","display_name":"recombinant factor VIIa","score":0.9950000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.909937858581543},{"id":"https://openalex.org/C2778385053","wikidata":"https://www.wikidata.org/wiki/Q134003","display_name":"Haemophilia","level":2,"score":0.6792271137237549},{"id":"https://openalex.org/C2776259030","wikidata":"https://www.wikidata.org/wiki/Q769508","display_name":"Bleed","level":2,"score":0.6751957535743713},{"id":"https://openalex.org/C2777232031","wikidata":"https://www.wikidata.org/wiki/Q2092064","display_name":"Haemophilia A","level":3,"score":0.5238635540008545},{"id":"https://openalex.org/C2777081929","wikidata":"https://www.wikidata.org/wiki/Q2562598","display_name":"Haemophilia B","level":4,"score":0.4947006404399872},{"id":"https://openalex.org/C2992139802","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Clotting factor","level":2,"score":0.46873125433921814},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4513517916202545},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4143192768096924},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37729597091674805},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3524285554885864},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3084109127521515}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000968116.45317.31","doi":"https://doi.org/10.1097/01.hs9.0000968116.45317.31","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000968116.45317.31","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10428241","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10428241","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10428241/pdf/hs9-7-e4531731.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:3dbcd2c1ffa24c5e98bfa7cf7643e274","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3dbcd2c1ffa24c5e98bfa7cf7643e274","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 7, p e4531731 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000968116.45317.31","doi":"https://doi.org/10.1097/01.hs9.0000968116.45317.31","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000968116.45317.31","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386024142.pdf","grobid_xml":"https://content.openalex.org/works/W4386024142.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405043740","https://openalex.org/W4386021597","https://openalex.org/W4392543341","https://openalex.org/W4361195612","https://openalex.org/W4361195679","https://openalex.org/W4417207042","https://openalex.org/W3208987463","https://openalex.org/W3217675254","https://openalex.org/W4287733501","https://openalex.org/W2987610752"],"abstract_inverted_index":{"Background:":[0],"Fitusiran,":[1],"an":[2],"investigational":[3],"subcutaneous":[4],"(SC)":[5],"siRNA":[6],"prophylactic,":[7],"targets":[8],"antithrombin":[9],"with":[10,18,82,90,109,114,158,175,230,247,269,274,329,439,487],"the":[11,153,208,213],"goal":[12],"of":[13,25,34,62,67,155,198,290,324,358,410,492,497],"rebalancing":[14],"haemostasis":[15],"in":[16,64,88,207,293,299,332,337,344,349,485],"people":[17],"haemophilia":[19,110],"A":[20,111,288,295,334,346],"or":[21,39,91,112,115,123,165,395,412,425,447],"B":[22,301],"(PwHA/B),":[23],"irrespective":[24],"inhibitor":[26],"status.":[27],"For":[28],"PwHA/B":[29,486],"receiving":[30],"fitusiran,":[31,313],"reduced":[32,56,244,315,380,455,473],"doses":[33,71],"clotting":[35],"factor":[36,168],"concentrates":[37],"(CFC)":[38],"bypassing":[40],"agents":[41],"(BPA)":[42],"are":[43],"recommended":[44],"to":[45,73,135,172,286,312,316],"treat":[46,74,173],"breakthrough":[47,75,156,281,415],"bleeds.":[48,76],"Previous":[49],"trials":[50],"(ATLAS-A/B":[51],"[NCT03417245],":[52],"ATLAS-INH":[53],"[NCT03417102])":[54],"reported":[55],"total":[57,289,353,474,480],"CFC/BPA":[58,70,80,86,128,195,214,255,279,308,341,458,469,475],"consumption":[59,81,409,461,476],"as":[60],"result":[61],"reduction":[63],"ABR,":[65],"number":[66,197,323,491,496],"injections":[68,434],"and":[69,144,177,179,201,212,234,262,296,318,335,347,368,460,488,495],"required":[72,278,432],"Aims:":[77],"To":[78],"explore":[79],"fitusiran":[83,140,209,248,270,330,384,422,440,466],"prophylaxis":[84,87,129,141,215,342,453,467,472],"vs":[85,254,340,385,423,441],"PwHA/B,":[89],"without":[92,116,184,236,437,489],"inhibitors.":[93,185],"Methods:":[94],"This":[95],"Phase":[96],"3,":[97],"multicentre,":[98],"multinational,":[99],"open-label":[100],"trial":[101],"(ATLAS-PPX,":[102],"NCT03549871)":[103],"enrolled":[104],"males":[105],"aged":[106],"\u226512":[107],"years":[108],"B,":[113],"inhibitors,":[117,176,490],"who":[118,443],"had":[119,302],"received":[120,383,421,444],"prior":[121],"CFC":[122,181,359,386,424,445],"BPA":[124,369,396,426,448],"prophylaxis.":[125,309,406,450,470],"Participants":[126,431],"continued":[127],"for":[130,152,182,226,280,414],"6":[131,145],"months,":[132],"before":[133],"switching":[134,285,311],"once-monthly":[136],"80":[137,219],"mg":[138],"SC":[139],"(1-month":[142],"onset":[143],"months":[146],"efficacy":[147,210,227],"period).":[148],"CFC/BPAs":[149],"were":[150,205,221,224,378],"used":[151,171],"management":[154],"bleeds,":[157],"BPAs":[159],"(activated":[160],"prothrombin":[161],"complex":[162],"concentrate":[163],"[aPCC]":[164],"recombinant":[166],"activated":[167],"VII":[169],"[rFVIIa])":[170],"PwH":[174,183],"FVIII":[178],"FIX":[180],"Primary":[186],"endpoint":[187,462],"was":[188,242,327,417],"annualised":[189],"bleeding":[190,456],"rate":[191],"(ABR).":[192],"Annualised":[193],"weight-adjusted":[194,354,481],"consumption,":[196],"treated":[199,267,304,325,493],"bleeds":[200,268,326,416,494],"infusions":[202],"per":[203,356,483],"bleed":[204,282,305,357,484],"assessed":[206],"period":[211],"period.":[216],"Results:":[217],"Overall,":[218],"participants":[220,277,292,298,320,382],"enrolled;":[222],"65":[223],"eligible":[225],"analyses":[228],"(19":[229],"inhibitors":[231,237],"[Cohort":[232,238],"A]":[233],"46":[235],"B]).":[239],"Estimated":[240],"ABR":[241],"significantly":[243,454],"by":[245,477],"61.1%":[246],"(2.9":[249],"[95%":[250,257],"CI:":[251,258],"1.7,":[252],"4.9])":[253],"(7.5":[256],"5.5,":[259],"10.1];":[260],"p=0.0008),":[261],"41":[263],"(63.1%)":[264],"experienced":[265],"zero":[266],"versus":[271,457],"11":[272],"(16.9%)":[273],"CFC/BPA.":[275],"Fewer":[276],"treatment":[283,501],"after":[284],"fitusiran.":[287],"18":[291],"Cohort":[294,300,333,338,345,350],"36":[297],"any":[303],"whilst":[306],"on":[307],"After":[310],"this":[314],"4":[317],"20":[319],"respectively.":[321],"Total":[322,407],"lower":[328,418],"(18":[331],"54":[336],"B)":[339],"(96":[343],"126":[348],"B).":[351],"Mean":[352],"dose":[355,482],"(FVIII=13.4":[360],"IU/kg,":[361,365,388,392],"SD:":[362,366,372,376,389,393,400,404],"5.5;":[363],"FIX=26.2":[364],"0.0)":[367],"(aPCC=34.1":[370],"U/kg,":[371,399],"16.1;":[373],"rFVIIa=38.2":[374],"\u00b5g/kg,":[375,403],"17.0)":[377],"markedly":[379],"when":[381,419],"(FVIII=45.3":[387],"41.8;":[390],"FIX=73.6":[391],"54.7)":[394],"(aPCC=":[397],"199.8":[398],"366.1;":[401],"rFVIIa=709.9":[402],"1163.8)":[405],"mean":[408,479],"FVIII/FIX":[411],"aPCC/rFVIIa":[413],"patients":[420],"prophylaxis,":[427,459],"respectively":[428],"(Table":[429],"1).":[430],"fewer":[433],"(with":[435],"inhibitors=26,":[436],"inhibitors=59)":[438],"those":[442],"(total=189)":[446],"(total=419)":[449],"Summary/Conclusion:":[451],"Fitusiran":[452,471],"results":[463],"consistently":[464],"favoured":[465],"over":[468],"reducing":[478,500],"injections,":[498],"thereby":[499],"burden.Keywords:":[502],"Hemophilia":[503]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-08-22T00:00:00"}